These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 29580282

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Differences in plasma and sputum biomarkers between COPD and COPD-asthma overlap.
    Iwamoto H, Gao J, Koskela J, Kinnula V, Kobayashi H, Laitinen T, Mazur W.
    Eur Respir J; 2014 Feb; 43(2):421-9. PubMed ID: 23794464
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Association between YKL-40 and asthma: a systematic meta-analysis.
    Jin Y, Song J, Xu F, Zhang D, He J, Zheng J, Zhang Y, Li J, Guo Y, Xu M, Yu X, Liu Y, Liu Q, Yan J.
    Sleep Breath; 2022 Sep; 26(3):1011-1022. PubMed ID: 34657273
    [Abstract] [Full Text] [Related]

  • 26. Utility of serum YKL-40 levels for identification of patients with asthma and COPD.
    Gon Y, Maruoka S, Ito R, Mizumura K, Kozu Y, Hiranuma H, Hattori T, Takahashi M, Hikichi M, Hashimoto S.
    Allergol Int; 2017 Oct; 66(4):624-626. PubMed ID: 28285848
    [No Abstract] [Full Text] [Related]

  • 27. Metabolomic signatures of asthma-COPD overlap (ACO) are different from asthma and COPD.
    Ghosh N, Choudhury P, Subramani E, Saha D, Sengupta S, Joshi M, Banerjee R, Roychowdhury S, Bhattacharyya P, Chaudhury K.
    Metabolomics; 2019 Jun 04; 15(6):87. PubMed ID: 31165288
    [Abstract] [Full Text] [Related]

  • 28. Phenotype of Asthma-COPD Overlap in COPD and Severe Asthma Cohorts.
    Joo H, Park SY, Park SY, Park SY, Kim SH, Cho YS, Yoo KH, Jung KS, Rhee CK.
    J Korean Med Sci; 2022 Aug 01; 37(30):e236. PubMed ID: 35916048
    [Abstract] [Full Text] [Related]

  • 29. The prevalence and clinical features of asthma-COPD overlap (ACO) definitively diagnosed according to the Japanese Respiratory Society Guidelines for the Management of ACO 2018.
    Yamamura K, Hara J, Kobayashi T, Ohkura N, Abo M, Akasaki K, Nomura S, Yuasa M, Saeki K, Terada N, Matsuoka H, Tambo Y, Nishikawa S, Sone T, Kimura H, Kasahara K.
    J Med Invest; 2019 Aug 01; 66(1.2):157-164. PubMed ID: 31064931
    [Abstract] [Full Text] [Related]

  • 30. [Correlation between expressions of myeloperoxidase and eosinophil cationic protein in sputum and clinical features of asthma-chronic obstructive pulmonary disease overlap].
    Yang H, Zhang Y, Zhang J, Pan J, Wang F, Luo X, Chen F.
    Nan Fang Yi Ke Da Xue Xue Bao; 2018 Sep 30; 38(10):1215-1221. PubMed ID: 30377121
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Increased urinary l-histidine in patients with asthma-COPD overlap: a pilot study.
    Oh JY, Lee YS, Min KH, Hur GY, Lee SY, Kang KH, Rhee CK, Park SJ, Khan A, Na J, Park YH, Shim JJ.
    Int J Chron Obstruct Pulmon Dis; 2018 Sep 30; 13():1809-1818. PubMed ID: 29892192
    [Abstract] [Full Text] [Related]

  • 34. Clinical Implications of Bronchodilator Testing: Diagnosing and Differentiating COPD and Asthma-COPD Overlap.
    Annangi S, Coz-Yataco AO.
    Respir Care; 2022 Apr 30; 67(4):440-447. PubMed ID: 35338095
    [Abstract] [Full Text] [Related]

  • 35. Heterogeneity of asthma-chronic obstructive pulmonary disease (COPD) overlap from a cohort of patients with severe asthma and COPD.
    Choi JY, Rhee CK, Yoo KH, Jung KS, Lee JH, Yoon HK, Ra SW, Lee MG, Jo YS.
    Ther Adv Respir Dis; 2023 Apr 30; 17():17534666231169472. PubMed ID: 37096829
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Sputum YKL-40 levels and pathophysiology of asthma and chronic obstructive pulmonary disease.
    Otsuka K, Matsumoto H, Niimi A, Muro S, Ito I, Takeda T, Terada K, Yamaguchi M, Matsuoka H, Jinnai M, Oguma T, Nakaji H, Inoue H, Tajiri T, Iwata T, Chin K, Mishima M.
    Respiration; 2012 Apr 30; 83(6):507-19. PubMed ID: 21968467
    [Abstract] [Full Text] [Related]

  • 40. The Value of Inflammatory Biomarkers in Differentiating Asthma-COPD Overlap from COPD.
    Li M, Yang T, He R, Li A, Dang W, Liu X, Chen M.
    Int J Chron Obstruct Pulmon Dis; 2020 Apr 30; 15():3025-3037. PubMed ID: 33244228
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.